Powered by HealthTechMovers.com
We added 4 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Iovance Biotherapeutics, Inc., IOVA
Summary: Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own immune system to eradicate cancer cells.
- Last Price: $17.43
- Price Change: $-0.04, -0.23%
- Yearly Gain: 139.09%
- Market Cap: $4.86B
- P/E Ratio: -8.38
Here are 3rd party ratings for IOVA:
- TipRanks.com: Buy
- TradingView.com: buy
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 34% (85 out of 250)
What is the sentiment on the street regarding Iovance Biotherapeutics, Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bullish
- Blogger Consensus:
- Media Buzz: Neutral
- Insider Signal: Balanced
- Investor Sentiment: Positive
- Hedge Fund signal: Medium Risk
If you are interested in IOVA or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on IOVA before you decide to make any investment.
Click here for chart >>
AbCellera Biologics Inc., ABCL
Summary: AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.
- Last Price: $5.08
- Price Change: $-0.04, -0.78%
- Yearly Gain: -39.52%
- Market Cap: $1.49B
- P/E Ratio: -9.96
Here are 3rd party ratings for ABCL:
- TipRanks.com: Buy
- TradingView.com: sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 34% (85 out of 250)
What is the sentiment on the street regarding AbCellera Biologics Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bearish
- Blogger Consensus:
- Media Buzz: Sell
- Insider Signal: Buying
- Investor Sentiment: Negative
- Hedge Fund signal: Medium Risk
If you are interested in ABCL or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on ABCL before you decide to make any investment.
Click here for chart >>
Viridian Therapeutics, Inc., VRDN
Summary: Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.
- Last Price: $20.17
- Price Change: $0.56, 2.86%
- Yearly Gain: -38.43%
- Market Cap: $1.20B
- P/E Ratio: -3.92
Here are 3rd party ratings for VRDN:
- TipRanks.com: Buy
- TradingView.com: buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Buy, Top 34% (85 out of 250)
What is the sentiment on the street regarding Viridian Therapeutics, Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bearish
- Blogger Consensus:
- Media Buzz: Neutral
- Insider Signal: Balanced
- Investor Sentiment: Positive
- Hedge Fund signal: High Risk
If you are interested in VRDN or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on VRDN before you decide to make any investment.
Click here for chart >>
AVITA Medical, Inc., RCEL
Summary: AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif.
- Last Price: $16.87
- Price Change: $-1.44, -7.86%
- Yearly Gain: 25.80%
- Market Cap: $433.67M
- P/E Ratio: -12.05
Here are 3rd party ratings for RCEL:
- TipRanks.com: Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 40% (100 out of 250)
What is the sentiment on the street regarding AVITA Medical, Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Bearish
- Blogger Consensus:
- Media Buzz: Neutral
- Insider Signal: Selling
- Investor Sentiment: Positive
- Hedge Fund signal: Medium Risk
If you are interested in RCEL or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on RCEL before you decide to make any investment.
Click here for chart >>
Thanks for reading!